Amarin Corp Plc (AMRN)

[KCSVEN]

They probably have right to tell doctors about study but different than full advertising to the general public.
Anything is possible but by putting it in the press release my guess is they will not have a full campaign until that 2Q time period.

Hoping they get an early expanded label though not counting on it to be early, expedited over standard was the big one and FDA generally goes to the full date or close to it. The sooner they get expanded label the sooner they can start getting lower tier coverage on insurance which, IMO, increases sales easily, cheaply and significantly.